Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 21 of Citius Pharmaceuticals, Inc.'s SEC filings and found 42 warrant series, 3 convertibles, 1 ATM program, 2 shelf registrations and 3 completed offerings on file for CTXR. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Sep 25, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
NCELNewcelX Ltd. Ordinary Shares
DYAIDyadic International, Inc.
RADXRadiopharm Theranostics Limited American Depositary Shares
KTTAPasithea Therapeutics Corp.
ATYRaTyr Pharma, Inc.
MRKRMarker Therapeutics, Inc.
NEUPNeuphoria Therapeutics Inc.
BCDABioCardia, Inc.
ALLRAllarity Therapeutics, Inc.
BOLTBolt Biotherapeutics, Inc.
BIVIBioVie Inc.
ABOSAcumen Pharmaceuticals, Inc.
AEONAEON Biopharma, Inc.
JSPRJasper Therapeutics, Inc.
PLURPluri Inc. Common Stock